Series C funding round for Black Diamond Therapeutics raising $85M in December 2019
Series C funding round for Black Diamond Therapeutics raising $85M in December 2019
| Investor | Firm Type | Partner |
|---|
Tavistock GroupLEAD | Venture Capital | — |
| Private | — | |
| Venture Capital | — | |
| Private | — | |
| Private | — | |
| Private | — | |
| Hedge Fund | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — |
This company has completed 3 funding rounds. Current round is highlighted.
Total Raised
$190M
Top Valuation
-
Black Diamond Therapeutics raised $85M in a Series C round.
The round was announced on 12/01/19.
The round was led by Tavistock Group.